A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine.
Saved in:
| Title: | A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine. |
|---|---|
| Authors: | Singh SK; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Plieskatt J; PATH's Malaria Vaccine Initiative, Washington, DC, United States., Chourasia BK; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Fabra-García A; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Garcia-Senosiain A; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Singh V; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Bengtsson KL; Novavax AB, Uppsala, Sweden., Reimer JM; Novavax AB, Uppsala, Sweden., Sauerwein R; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Jore MM; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Theisen M; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. |
| Source: | Frontiers in immunology [Front Immunol] 2021 Jan 11; Vol. 11, pp. 606266. Date of Electronic Publication: 2021 Jan 11 (Print Publication: 2020). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33505395 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Singh+SK%22">Singh SK</searchLink>; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Plieskatt+J%22">Plieskatt J</searchLink>; PATH's Malaria Vaccine Initiative, Washington, DC, United States.<br /><searchLink fieldCode="AU" term="%22Chourasia+BK%22">Chourasia BK</searchLink>; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Fabra-García+A%22">Fabra-García A</searchLink>; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Garcia-Senosiain+A%22">Garcia-Senosiain A</searchLink>; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Singh+V%22">Singh V</searchLink>; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Bengtsson+KL%22">Bengtsson KL</searchLink>; Novavax AB, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Reimer+JM%22">Reimer JM</searchLink>; Novavax AB, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Sauerwein+R%22">Sauerwein R</searchLink>; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Jore+MM%22">Jore MM</searchLink>; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Theisen+M%22">Theisen M</searchLink>; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2021 Jan 11; Vol. 11, pp. 606266. <i>Date of Electronic Publication: </i>2021 Jan 11 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33505395 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2020.606266 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 606266 Titles: – TitleFull: A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Singh SK – PersonEntity: Name: NameFull: Plieskatt J – PersonEntity: Name: NameFull: Chourasia BK – PersonEntity: Name: NameFull: Fabra-García A – PersonEntity: Name: NameFull: Garcia-Senosiain A – PersonEntity: Name: NameFull: Singh V – PersonEntity: Name: NameFull: Bengtsson KL – PersonEntity: Name: NameFull: Reimer JM – PersonEntity: Name: NameFull: Sauerwein R – PersonEntity: Name: NameFull: Jore MM – PersonEntity: Name: NameFull: Theisen M IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 01 Text: 2021 Jan 11 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 11 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |